I think there's some merit in that. I think its also fairly...

I think there's some merit in that. I think its also fairly generic. How many are at equivalent stage and have a 20yr track record? Prior engagement from potential suitors, etc

I wonder if it reflects on our SP. As you point out we are at precipice of delivery - stated as this quarter!

M&A is increasing in US btw.

Please click this URL to join. https://us02web.zoom.us/w/84146359586?tk=UeR18c1y7jXpFHSz4PyQJLNqbBESRJhjMrZcoBAi_nQ.DQYAAAATl4ONIhZwVTRLTUg2Y1EwR1ExMXdaSUh4NG9BAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA&uuid=WN_bJZ0mkCnTT6kOvAOKlKrWA

Description: In biotech, a recovery is already well underway. Expected interest rate cuts and improving valuations across public and private markets are creating a compelling environment for deals, entrances, exits, and trades to take shape.